Abstract
The combinatorial approach of drugs (co-therapy) has been widely used in cancer therapy. Recent clinical studies have shown that treatments that combine free drugs may increase tumor regression rates compared to individual administration. However, a relevant aspect to be considered is related to the dose-dependent toxicity of the co-therapeutic administration of drugs. Moreover, this obst…